A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.
Baher ElEzbawyAhmad Nader FasseehAmal SedrakRanda EldessoukiMary GamalMariam EldebeikyHanaa AmerShimaa AkeelAhmad MorsyAmira AminAmr ShafikSherif AbazaZoltán KalóPublished in: Journal of pharmaceutical policy and practice (2022)
The created MCDA tool is capable of objectively comparing similar off-patent oncology medicines by considering multiple value attributes and providing reliable scoring functions for each.